SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Chiltern eyes Asian expansion with acquisition of Pacific Clinical Research

Chiltern expands again, this time in Asia

In a sign of further industry consolidation, CRO Chiltern has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. Financial terms were not announced.

Related news

News in brief

Australia’s largest clinical CRO Novotech has expanded its services into China with a new office in Shanghai.

Consort Medical will buy UK contractor Aesica for £230m from Silverfleet Capital in a deal announced today.

Fraudsters who hoodwinked Medidata Solutions into transferring $4.8m to an "overseas" account this month did not access customer data says the clinical trial IT firm.

CRO PPD has exercised its option to acquire the remaining minority ownership interest of X-Chem for an undisclosed sum. X-Chem will continue to operate as a small molecule discovery company with its entire existing staff and management team. 

Merck KGaA’s acquisition of Sigma-Aldrich is testament to Big Pharma’s growing interest in personalized medicine says Horizon Discovery, which has bought Sage Labs for $48m (€38m).

Global Industry News

'Worst addiction epidemic in US history' sparks call for Hamburg's resignation from in-PharmaTechnologist.com

An anti-addiction group has called for a change in leadership at the US FDA following the approval of Zohydro and other high-dose opioid analgesics.

Cell-culture flu vaccines shipped from Novartis plant for 2014-5 season from BioPharma-Reporter.com

Novartis has shipped the first of its cell-culture - rather than chicken egg - based vaccines for the 2014-2015 flu season from its North Carolina facility.

Patents and profits: the battle to own CRISPR from BioPharma-Reporter.com

CRISPR, the gene-editing technology that could revolutionise biologics, is set to become a patent battleground as companies vie over who owns the tool and its products, says an intellectual property expert.

News in brief

SAFC, Baxter partner to offer ADC contract manufacturing from BioPharma-Reporter.com

SAFC and Baxter’s BioPharma unit are working together to contract manufacture ADCs (antibody drug conjugates) for biopharma companies.

TC BioPharm constructs clinical manufacturing facility in Scotland from BioPharma-Reporter.com

Scotland-based TC BioPharm has completed its work on a clinical manufacturing facility in Glasgow.

USP offers support for WHO’s biological qualifier plan from BioPharma-Reporter.com

USP (US Pharmacopeia) is offering its support for efforts from the WHO to develop a global approach to the naming of all biologics.

Spotlight

Public CROs are sign of booming market, not PE apathy say experts
News focus

Public CROs are sign of booming market, not PE apathy say financial advisors

Experts have predicted more CROs will go public as Private Equity looks to get a return on...

Biologics trials: the ‘stretched’ global supply chain

Biologics trials: the ‘stretched’ global supply chain

The high cost and complexity of producing biopharmaceuticals for clinical trials limits supplies and makes effective logistics...

Charles River to lay off up to 30 employees following NCI contract end

Charles River to lay off up to 30 employees following NCI contract termination

Early phase CRO (contract research organization) Charles River Laboratories will lay off between 26 and 30 employees...

Pharma firms ‘saving billions’ in research – by giving away their tech

Pharma firms ‘saving billions’ in research – by giving away their tech

Pharma’s biggest players have donated more than $102m ($78m) of technology in a project to transform data...

CMO Kentucky Bioprocessing grows Ebola mAb from tobacco

CMO Kentucky Bioprocessing grows Ebola mAb from tobacco

ZMapp, the experimental Ebola therapy given to a handful of infected patients in West Africa, is being...

CRO Crown: Advancing in vitro models could benefit preclinical world

Crown Bio: New in vitro technology could revolutionise drug discovery

Increasing the predictivity of in vitro systems could cut the costs of drug development and shift preclinical...

On demand Supplier Webinars

A brief history of bioavailability
William Reed Business Media
Bioavailability market dynamics
William Reed Business Media
All supplier webinars